S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KTRA Kintara Therapeutics Inc

0.155

0.007 (4.73%)

May 02 2024 - Closed

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
ktra_ars_june_30_2022.pdf

Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Kintara Therapeutics Charts.

Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Kintara Therapeutics Charts.

Kintara Therapeutics, Inc. News

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Friday 5 April 2024 (4 weeks ago) • PR Newswire (US)

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Wednesday 3 April 2024 (4 weeks ago) • PR Newswire (US)

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab
Wednesday 27 March 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
Wednesday 14 February 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
Monday 12 February 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Monday 18 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 18 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 December 2023 (5 months ago) • Edgar (US Regulatory)

More Kintara Therapeutics, Inc. News Articles

Voip Pal Com (QB)

BlackStar Enterprise (PK)

Global Developments (PK)

Brookmount Explorations (PK)

Trump Media and Technology

Globestar Therapeutics (PK)

CBD of Denver (PK)

Bell Buckle (PK)

International Star (PK)

Therapeutic Solutions (PK)

Atacama Resources (PK)

Moon Equity (PK)

Progressive Care (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions